Health Professionals ▶MUSC Online Videos Home ▶Course Catalog▶ Course Details
Course Details
Course Title Panel Discussion: How Do We Continue & Speed Up The Current Progress That Has Been Made In The Treatment Of HFpEF Over The Past Decade?
Presented Date 07/18/2025
Expiration Date 08/08/2025
Presenter(s) Ryan Tedford, M.D
This Presenter does have relevant Financial Relationships to disclose.
   Consultant - Abbott, Acorai, Adona, Alleviant*, Aria CV Inc., Acceleron, Boston Scientific, CVRx, Cytokinetics*, Endotronix, Edwards LifeSciences, Fauna Bio, Gradient, Imbria*, Medtronic, Merck, Pulmovant*, Restore Medical, Tempus AI, United Therapeutics
   Other Steering Committee - Abbott, Edwards, Endotronix, Gradient, Merck and Tempus AI
   Other Research Advisory Committee - Abiomed

Sheldon Litwin, M.D.
This Presenter does have relevant Financial Relationships to disclose.
   Consultant Description of Other relationship - Alleviant, Axon, Corvia, Eli Lilly*, and Novo Nordisk

Daniel Silverman, M.D.
This Presenter does have relevant Financial Relationships to disclose.
   Other Local Investigator for clinical studies - Boston Scientific, Alleviant, Acceleron, Merck, and Tenax

Michael Zile, M.D.
This Presenter does have relevant Financial Relationships to disclose.
   Other Consultant /Advisory Board - Abbott Cardiovascular Systems, Inc., Adona Medical, Alleviant Medical, Inc, Aria CV, Avery Therapeutics, Bayer AG, CVRx, Inc., DIASTOL Therapeutics, EBR, Edwards Lifesciences, Eli Lilly, GenKardia, Innoventrics, Intershunt, Kestra Medical, Medtronic, Novartis, Pulnova, V Wave, Vectorious, and WhiteSwell
This activity was supported by an education grant or any in-kind support.
Edwards Life Sciences, Tenax Therapeutics, V Wave, Inc

The Medical University of South Carolina designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Description This video is part of the Charleston HFpEF Conference.
Objectives Discuss methods for overcoming the perceived barriers to prescription of beneficial medications for HFpEF
Increase proficiency in the use of social media for learning about HFpEF, disseminating findings and treating patients with HFpEF
Step 1
Watch the course video.
Step 2
1. The below link will take you to the CME Tracker Publisher Portal. Please make sure that the settings on your computer, tablet or phone allows for "pop-ups"
2. Sign in (or create an account) to generate certificate
3. The activity code will self-populate, click “Submit”
4. A pop-up box will appear that says “This activity has a required test” click “ok”
5. Complete the quiz. You will need to score 100%. You can retake the quiz as many times as necessary.
6. After completing the quiz, click “Continue” and “ok” when the score of 100% appears
7. Complete the evaluation and then “Submit”
8. Print or save your credit letter

CME Tracker - Claim Credit

Help

If you experience technical or accessibility issues, have questions about CME webcasting, or need assistance with webcast CME credit, please email us.